Company profile for Synthorx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Synthorx is a biopharmaceutical company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Our proprietary, first-of-its-kind platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics called Synthorins. Based on our preclinical studies, we believe our platform technology can generate a pipeline of additional therapeutics t...
Synthorx is a biopharmaceutical company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Our proprietary, first-of-its-kind platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics called Synthorins. Based on our preclinical studies, we believe our platform technology can generate a pipeline of additional therapeutics that are differentiated compared to drugs that have been engineered by other means.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11099 North Torrey Pines Road, Suite 290 La Jolla, CA 92037
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

 https://www.biopharmadive.com/news/sanofi-synthorx-il2-cancer-drug-delay/635206/

Ben Fidler BIOPHARMADIVE
29 Oct 2022

https://endpts.com/bayer-backs-a-george-church-spinout-trying-to-turn-lab-invented-amino-acids-into-a-new-class-of-protein-therapies/

Jason Mast ENDPTS
04 Nov 2021
Sanofi drops 'intriguing' data on rival to Bristol Myers' bempeg
Sanofi drops 'intriguing' data on rival to Bristol Myers' bempeg

10 Apr 2021

// Nick Paul Taylor FIERE BIOTECH

https://www.fiercebiotech.com/biotech/sanofi-drops-intriguing-data-rival-to-bristol-myers-bempeg

Nick Paul Taylor FIERE BIOTECH
10 Apr 2021
Asher Bio banks $55M to deliver more selective cytokines
Asher Bio banks $55M to deliver more selective cytokines

23 Mar 2021

// Amirah Al Idrus FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/asher-bio-sets-out-55m-to-deliver-pros-cytokines-and-other-immunotherapies-without-cons

Amirah Al Idrus FIERCEBIOTECH
23 Mar 2021

https://endpts.com/laura-shawver-is-about-to-join-a-lineup-of-biotech-ceos-enjoying-overnight-fortunes-courtesy-of-the-biotech-ipo-boom/

John Carroll ENDPTS
04 Dec 2020

https://endpts.com/sanofi-teams-up-with-merck-to-pair-keytruda-with-a-next-gen-il-2-candidate-from-the-synthorx-buyout/

N. DeFeudis ENDPTS
29 Oct 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty